COHERUS ONCOLOGY INC (CHRS) Stock Balance Sheet
NASDAQ:CHRS • US19249H1032
Current stock price
1.8 USD
+0.09 (+5.26%)
At close:
1.8183 USD
+0.02 (+1.02%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 88.88M | 125.99M | 102.89M | 63.50M | 417.20M | |||
| Marketable Securities | 83.25M | 0.00 | 14.86M | 128.10M | N/A | |||
| Receivables | 18.42M | 122.33M | 260.52M | 110.00M | 123.00M | |||
| Inventories | 3.17M | 70.09M | 62.60M | 38.80M | 37.60M | |||
| Other Current Assets | 12.99M | 23.17M | 34.76M | 40.80M | 24.50M | |||
| Total Current Assets | 206.71M | 341.58M | 475.63M | 381.20M | 602.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | 4.30M | 7.36M | 11.03M | 14.40M | 16.00M | |||
| Goodwill | N/A | 0.00 | 943.00K | N/A | 900.00K | |||
| Intangibles | 46.24M | 53.65M | 70.73M | 5.90M | 2.60M | |||
| Other Non-Current Assets | 1.10M | 45.95M | 71.27M | 79.20M | 57.40M | |||
| Total Non-Current Assets | 51.64M | 106.95M | 153.97M | 99.60M | 77.00M | |||
| TOTAL ASSETS | 258.34M | 448.53M | 629.60M | 480.80M | 679.30M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 0.00 | 1.15M | 721.00K | 1.20M | 700.00K | |||
| Accrued Expenses | 65.41M | 228.73M | 292.53M | 126.00M | 148.40M | |||
| Accounts Payable | 9.91M | 28.46M | 35.22M | 11.50M | 16.20M | |||
| Other Current Liabilities | 65.06M | 24.65M | 3.30M | N/A | N/A | |||
| Total Current Liabilities | 140.39M | 282.98M | 331.77M | 138.70M | 165.30M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 51.08M | 292.52M | 473.72M | 472.50M | 408.80M | |||
| Deferred Taxes/Income | 1.10M | 1.10M | 1.10M | N/A | N/A | |||
| Other Non-Current Liabilities | 4.76M | 3.92M | 16.44M | 7.10M | 7.50M | |||
| Total Non-Current Liabilities | 56.94M | 297.54M | 491.26M | 479.60M | 416.30M | |||
| TOTAL LIABILITIES | 197.33M | 580.52M | 823.03M | 618.30M | 581.60M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.38B | -1.55B | -1.58B | -1.34B | -1.05B | |||
| Additional Paid In Capital | 1.44B | 1.42B | 1.39B | 1.20B | 1.15B | |||
| Minority Interest | N/A | N/A | N/A | N/A | N/A | |||
| Common Shares | 12.00K | 12.00K | 11.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -195.00K | -275.00K | -248.00K | -200.00K | -300.00K | |||
| Shares Outstanding | 121.15M | 115.61M | 112.22M | 78.90M | 76.90M | |||
| Tangible Book Value per Share | 0.12 | -1.61 | -2.36 | -1.82 | 1.23 | |||
| Total Shareholders' Equity | 61.01M | -131.99M | -193.43M | -137.40M | 97.70M | |||
| TOTAL LIABILITIES AND EQUITY | 258.34M | 448.53M | 629.60M | 480.80M | 679.30M | |||
| Statistics | ||||||||
| Debt/Equity | 0.84 | -2.22 | -2.45 | -3.44 | 4.18 | |||
| Current Ratio | 1.47 | 1.21 | 1.43 | 2.75 | 3.64 | |||
| Return On Assets (ROA) | 65.04% | 6.36% | -37.78% | -60.69% | -42.26% | |||
| Return On Equity (ROE) | 275.39% | N/A | N/A | N/A | -293.86% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexgc) | N/A | N/A | N/A | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21